SCHEMBL30609969

SCHEMBL30609969

C[C@@H](NC(=O)[C@H](N)CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)O)C(=O)O

nearest known ligand 0.65

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
▸ BACE1 P56817 9/20 0.51
▸ BACE2 Q9Y5Z0 2/20 0.51
▸ MMP2 P08253 1/20 0.51
▸ OPRK1 P41145 1/20 0.49
▸ GNPAT O15228 1/20 0.48
▸ PTPN1 P18031 1/20 0.48
▸ OPRM1 P35372 2/20 0.48
▸ OPRD1 P41143 2/20 0.48
▸ CTSD P07339 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30609958 1.00 BACE1 (0.51) BACE1BACE2MMP2OPRK1GNPAT
SCHEMBL13296501 0.96 BACE1 (0.54) BACE1BACE2MMP2CTSD
SCHEMBL30799335 0.94 MMP2 (0.55) BACE1MMP2OPRK1GNPATOPRM1
SCHEMBL31167399 0.94 MMP2 (0.57) MMP2OPRK1GNPAT
SCHEMBL31167406 0.94 MMP2 (0.57) MMP2OPRK1GNPAT
SCHEMBL30799698 0.93 BACE1 (0.57) BACE1MMP2OPRK1CTSD
SCHEMBL31181273 0.92 BACE1 (0.54) BACE1BACE2OPRK1GNPATPTPN1
SCHEMBL31554972 0.92 MMP2 (0.56) BACE1MMP2OPRK1GNPATOPRM1
SCHEMBL30497073 0.92 MMP2 (0.56) BACE1MMP2OPRK1GNPATOPRM1
SCHEMBL30118074 0.91 MMP2 (0.56) BACE1BACE2MMP2OPRK1GNPAT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116970040-A Opioid multi-target-spot cyclohexapeptide molecule with amide bond ring formation, and preparation and application thereof 兰州大学 2023-10-31 — — CN claimed
CN-116970040-A Opioid multi-target-spot cyclohexapeptide molecule with amide bond ring formation, and preparation and application thereof 兰州大学 2023-10-31 — — CN disclosed
Send feedback